Results 171 to 180 of about 119,784 (210)

Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis

Lancet, The, 2020
Mauro Chiarito, Francesco Cannata, Davide Cao   +2 more
exaly  

Inherited C1 inhibitor deficiency.

Complement and inflammation, 1989
The paper reports our experience of a 15-year follow-up of 179 patients with hereditary angioedema (HAE). The disease is transmitted as an autosomal dominant trait and two variants have been described: type I characterized by functional and antigenic C1-inhibitor (C1-INH) deficiency and type II with normal or upper normal C1-INH antigenic levels but no
openaire   +1 more source

C1 INHIBITOR IN MALIGNANT DISEASES

The Lancet, 1976
P J, Lachmann, J, Wragge-Morley
openaire   +2 more sources

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

Lancet, The, 2011
Klemens Budde, Claudia Sommerer, Petra Reinke   +2 more
exaly  

Hereditary angioedema with normal C1-inhibitor activity in women

Lancet, The, 2000
Konrad Bork
exaly  

C1 inhibitor

2006
openaire   +1 more source

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial

Lancet, The, 2017
Marc A Riedl, Dumitru Moldovan, Avner Reshef   +2 more
exaly  

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial

Lancet, The, 2007
Vivian Wing Yan Lee, Henry Lik Yuen Chan
exaly  

C1 Inhibitor

2008
openaire   +1 more source

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

Lancet, The, 1999
Andrew Carr, Katherine Samaras
exaly